ABSTRACT: Tendinopathy of the long head of the biceps (TLHB) involves various types of extracellular matrix degeneration, but previous studies have not evaluated elastic fibers. The purpose of this study was to investigate elastic fiber distribution in long head of the biceps (LHB). The TLHB tendons of 16 consecutive patients (eight men and eight women; average age of 55.75 years; age range of 40-71 years) were transected and harvested. Three cadaveric LHB tendons were used as the control group. The expression of collagen type I was decreased, but type III was increased in TLHB. Disruption of elastic fibers was particularly observed in grade II specimens where the level of elastase-positive staining was significantly higher than in grade I specimens. Elastic fibers were not observed in the grade III area, implying a higher expression of elastase than in the grade I area. Results of Western blotting showed that the expression of elastin was higher in the control group and the levels of elastin significantly decreased in grades II and III of TLHB. Levels of osteopontin and elastase were increased in primary culture of human tenocytes after experiencing elastic derived peptide treatment. These results suggested that elastase may be caused by the disruption of elastic fibers in the development of chronic tendinopathy and that elastic derived peptide may enhance elastase and osteopontin expression. ß
Tendinopathy of the long head of the biceps (TLHB) is caused by inflammation, degeneration, overuse, and trauma. 1 Damage to the long head of the biceps (LHB) is typically clinically observed in conjunction with rotator cuff tears (RCTs), but rarely in isolation. 2 Disorders of the LHB tendon are associated with RCTs in up to 90% of cases because they may produce pressure and friction on the biceps tendon, which results in lesions on the LHB tendon. 3, 4 In the shoulder, specifically the tendons of the rotator cuff and the insertion of the LHB on the superior glenoid rim, is a well-recognized location of calcified tendinopathy. 5 Because these lesions may cause substantial shoulder pain and dysfunction, the mechanism of pathogenesis is largely unknown. 6 Elastase is an inflammatory protease and a predictive marker of inflammation and neutrophils. 7, 8 Inflammation is initiated by neutrophils in the early stage of tendon healing, indicating that elastase may be involved in this process. 9 However, the role of elastase in clinical tendinopathy is unknown. We have previously shown that peritendinous elastase treatment induces tendon degeneration in rats, indicating that elastase may cause changes in extracellular matrices (ECMs). 10 Elastase breaking down elastic fibers has been reported in various diseases, such as aneurysms and atherosclerosis. [11] [12] [13] Degradation of elastin caused by activated elastase results in the release of soluble elastin-derived peptides (EDPs). EDPs may affect matrix metalloproteinase (MMP) activity, which influences vascular calcification through mediated osteogenic responses in smooth muscle cells. 14 Similarly, calcification occurs in RCTs 15 and in TLHB. 16 Several studies have suggested that collagen degradation is critical in the development of tendon degeneration in rotator cuff, patellar, and Achilles tendons. [17] [18] [19] [20] Types I and III collagen fibers are particularly crucial and abundant in the tendon. Mild and moderate matrix degeneration resulting from tendinopathy characteristically shows collagen arrangements with decreased type I collagen and increased type III collagen. [21] [22] [23] Elastic fiber is also a type of ECM component that affects the mechanical functioning of a tendon. 24, 25 Elastic fibers in flexor tendons are not dispersed uniformly, but are confined to restricted locations; they form a three-dimensional (3-D) network of thin fibers that interpenetrate the array of collagen fibers. 26 Specifically, elastic fibers are confined to the outermost cell layer 27 and near the insertion site where fibrillation and delamination occur in TLHB. 28 According to the role of elastic fibers in the development of TLHB is largely unknown, we try to examine the condition of elastic fibers and related protein levels in TLHB.
MATERIALS AND METHODS

Collection of Human Specimens
who underwent arthroscopic repairs of RCTs and release of the TLHB at our hospital between January 2013 and January 2014 because of refractory biceps tendinopathy. None of the patients were injected with corticosteroids, nor had undergone a previous surgical procedure on the affected shoulder. A tear of the LHB (>50% of the diameter of the tendon) was found in all patients by using arthroscopy. Three LHBs were obtained from three fresh cadaveric donors (two men and one woman; average age of 50 years; age range of 45-56 years), which served as controls. These donors were diagnosed without any significant tendon diseases in 1 year before they expired. After thorough gross examination, the intra-articular tendinous portion of the LHB was removed. Medical records showed that none of the patients had sustained an acute or overuse injury to the LHB, nor had they taken corticosteroids during the previous 5 years. The TLHB specimens were cut into three pieces. One piece was for cell isolation and the second one was for sectioning followed by staining. The third one was used to analyze the protein levels by Western blot.
Tissue Preparation and Staining
For histological examination, tendons were fixed in 4% formalin, embedded longitudinally in paraffin, and cut into 4-mmthick cryosections for staining. Each tissue block was sectioned and taken one every five cuts. Each slide held two sections and five slides were stained for each staining method. Tendon morphology was detected using hematoxylin-and-eosin (H&E) staining. Elastic and collagen fibers were detected using Verhoeff-Van Gieson staining. Paraffin sections were used for immunohistochemical (IHC) staining. After deparaffinizing and rehydrating the sections, antigen retrieval was performed using a citrate buffer (Bio SB, Santa Barbara, CA) at 90˚C for 30 min. Endogenous peroxidase activity and blocking were quenched with an Expose Mouse and Rabbit Specific HRP/DAB Detection IHC kit (ab94710, Abcam, UK). Sections were stained overnight in a humid chamber at 4˚C with specific antibodies against elastase (ab21595, dilution 1:100, Abcam, UK), type I collagen (ab292, dilution 1:1,000, Abcam, UK), or type III collagen (ab7778, dilution 1:1,000, Abcam, UK). After the sections were washed three times, goat anti-rabbit HRP-conjugate secondary antibody (ab94710, Abcam, UK) was performed. Localization of these proteins was visualized by adding 3, 3 0 -diaminobenzidine substrate solution and by incubating for 3 min. Hematoxylin was used for counterstaining.
Histologic Grading and Detection of a Positive Ratio for Elastase All samples of the ECM structure were graded into grades I, II, or III by using the following criteria as described from previous studies [29] [30] [31] [32] : Grade I: Slightly degraded collagen structure with slight waviness and minimal splitting between contiguous fiber bundles; Grade II: Moderately degraded collagen structure with some separation between bundles, increased waviness, loss of parallel arrangement, and moderate fiber fragmentation; Grade III: Severely degraded collagen structure with complete loss of fiber orientation and severely fragmented fibers. All grading was performed and photographed using a magnification of 400Â (Zeiss Axio-A1 system). The grading was determined by at least two orthopedic surgeons using the double-blinded method. Using IHC staining, 10 fields of one section were randomly photographed in serial grade. The percentage of the positive ratio was counted in the elastase-positive cells (i.e., the total cell number of each chosen field). The calculation was determined by at least two orthopedic surgeons using the double-blinded method.
Tendon Primary Culture
Primary culture of TLHB tenocytes was isolated from all injured tendons of TLHB patients. Passage 3 were used in all experiments. 33 Cells were cultured in 6-well plates (1.5 Â 10 5 /well) in Dulbecco's modified Eagle's medium (Cellgro-Mediatech, Herndon, VA) containing 10% fetal bovine serum (Whittaker Bioproducts, Walkersville, MD), 100 U/ml penicillin, and 100 U/ml streptomycin (Gibco, Rockville, MD) in a humidified incubator at 37˚C with 5% CO 2 . Media were replenished every 3 days. The elastin peptides (CB 573, Elastin Products, Owensville, MO) were a mixture of fragments with molecular weights ranging from 1,000 to 60,000 Da, purified from bovine neck ligament, and highly soluble in water. They contained the specific repeating sequence VGVAPG. Experimental agents in culture medium were administered as follows: 20 mg/ml soluble elastin peptides, 50 mg/ml soluble elastin peptides, and 100 mg/ml soluble elastin peptides. Protein expressions were analyzed after 24 h of treatment.
14 Control groups were revived bovine serum albumin.
Western Blot Analysis
All samples were random selected from 18 specimens of TLHB. T1-T5 samples were randomly selected from 18 specimens of TLHB. The protein concentration of each sample was determined using a BCA protein assay kit (Bio-Rad). Precasted 10% polyacrylamide gels (Hoefer) were loaded with equal amounts of whole rat tendon homogenates, were electrophoresed, and were combined with nitrocellulose. Primary antibody against elastase (Cat#ab21595, dilution 1:500, Bio-SB, UK), elastin (Cat#ab21610, dilution 1:500, Abcam, UK), type I collagen (Cat#ab292, dilution 1:5,000, Abcam, UK), type III collagen (Cat#ab7778, dilution 1:5,000, Abcam, UK), and osteopontin (Cat#NB110-89062, dilution 1:1,500, NOVUS, Littleton, CO) were used, and secondary antibody was obtained from Sigma-Aldrich (dilution 1:5,000). Protein immunoreactivity was visualized using the Biochemi system (CA 91786). Molecular weight was determined using additional lanes loaded with prestained protein standards (Fermentas, SM0671) and a-tubulin was used as an internal control.
Statistical Analysis
All data were presented as mean AE standard error. Betweengroup differences were compared using a Mann-Whitney t-test. The quantification results of Western blot analysis were analyzed using Student T-test. A probability value <0.05 was considered statistically significant. Prism 4.0 software was used to conduct statistical analyses.
RESULTS
General Histological Change in Human Specimens
In the control sections, tightened collagen fibers appeared and formed a parallel pattern perpendicular to the longitudinal axis of the fibers. Only slight splitting was observed between bundles and nearly all tendon cells were spindle-shaped and aligned with the orientation of the fibers (Fig. 1A, E, and I) . The primary morphological characteristics of tendinopathy (i.e., collagen fiber disorganization) were observed for mild tendinopathy (grade I). The alignment of collagen fibers became wavy in mild tendinopathy tendons and showed several disorganized areas (Fig. 1B, F , and J). In moderate tendinopathy (grade II), including splitting and fragmentation of fiber bundles, we observed increases in small blood vessels and in the number of cells. A large proportion of the cells lost parallel alignment and became rounded; most cells were aggregated and located around small blood vessels (Fig. 1C, G, and K) . In addition, for severe tendinopathy (grade III), the parallel collagen fiber pattern was completely lost and replaced with a disorganized arrangement of highly fragmented fibers and a rare round cell morphology with rounded nuclei known as a chondrocyte phenotype. Chondro-like cells were also found in the lesion sites (Fig. 1D) . We examined the alignment of ECM by immunostaining of types I (Fig. 1E-H ) and III collagen (Fig. 1I-L) . Substantial levels of variation were observed among grades. The control and grade I specimens, which possessed relatively normal type I collagen fibers, were strongly stained and several wavy type I collagen fibers in the grade I specimen were discovered. The staining of type I collagen of grade II areas was slightly decreased, but the staining of type III collagen became stronger. In grade III, the staining of type I collagen was dramatically decreased, whereas type III collagen appeared to be strongly stained. As observed by H&E staining, the type III collagen staining formed discontinuous and fragmented structures. Western blotting results further proved that the protein levels of type I collagen were decreased in TLHB specimens with increased type III collagen, but not in the control (Fig. 1M and  N) . These results indicated a gradually disorganized ECM in TLHB along with its pathogenesis.
Distribution of Elastic Fibers in Various Grades
Because the collagen structures of the tendon were disorganized in TLHB specimen along with its pathogenesis, we were interested in whether the organization of other ECM proteins was also changed, such as for elastin. Results from Verhoeff-Van Gieson staining showed regular elastic fibers in the control and grade I specimens of TLHB. Regular elastic fibers ( Fig. 2A and B, arrows) in these specimens were thin and parallel Figure 1 . H&E stained sections of specimens with TLHB: Control (A), normal and tight collagen structures. TLHB specimens: Grade I (B), with slightly wavier collagen bundles. TLHB specimens: Grade II (C), with an increased cell population and angiogenesis. TLHB specimens: Grade III (D), with a disorganized and decreased cell population; the parallel collagen fiber pattern was completely lost. Captured using a microscope with a magnification of 400Â. IHC stained sections of specimens with TLHB: (E and I) the control was most strongly stained for type I collagen around the cells and most weakly stained for type III collagen around the cells. (F and J) The grade I area was stained with the same pattern as the control specimens were stained. (G and K) In the grade II area, type III collagen was more strongly stained compared with the control. (H and L) In the grade III area, the type I collagen stain dramatically decreased compared with the control, but the type III collagen was more strongly stained than the control (400Â magnification). (M) Western blotting showed that the protein levels of type I collagen decreased in TLHB specimens, but increased for type III collagen. (C ¼ control specimens, T ¼ TLHB specimens) (N) Quantification of the Western blot. Results were quantified using ImageJ image processing software (http://rsb.info.nih.gov/ij/). Data are means AE SE, n ¼ 3;
ÃÃÃ p < 0.001, compared with controls.
INVOLVEMENT OF ELASTASE IN TENDINOPATHY
to the collagen fibers and located near the tenocytes. However, degeneration and disruption of the elastic fibers was specifically observed in the grade II specimens (Fig. 2C ). Elastic fibers in most grade II specimens were disarranged (circle) and fragmented. Most elastic fibers were thick (Fig. 2C, arrows) , short, and not located near the tenocytes. In all grade III specimens (Fig. 2D) , elastic fibers completely disappeared, including those near the tenocytes. Western blotting was used to determine the protein levels of elastin in TLHB. Our results indicated that elastin was also markedly decreased in TLHB specimens ( Fig. 2E  and F ).
Elastase Expression in TLHB Because the above results showed possible degradation of elastin in TLHB specimen, we sought to investigate the levels of elastase in TLHB samples. We examined the presence of elastase using IHC staining, which was correlated with the histological grading of the tendinopathy (Fig. 3) . The staining of elastase was rarely observed in the control specimen and only mild staining of elastase was observed in the grade I specimen. However, the percentage of elastase-positive cells per unit area of the grade II ECM structure was 81.96% AE 10.2 ( Fig. 3C and G) and that of the grade III ECM structure was 89.49% AE 3.98 ( Fig. 3D and G); these were significantly higher than that of the grade I ECM structure at 11.96% AE 7.26 (p < 0.001) (Fig. 3B and G) . Western blotting results showed that protein levels of elastase in TLHB specimens were significantly higher than in the control group (Fig. 3E and F) . In addition, the elastin antibody may interact with the degraded elastin fragments, we indeed examined the protential degradation pattern in our Western blot results.
Comparing with the samples from control, we observed very similar patterns of the protein bands at the molecular weight lower than elastin in TLHB samples (data not shown). We speculated that these protein bands were the non-specific bands that generated by the antibody non-specificity, suggesting that the elastin antibody is not likely to interact with the degraded elastin fragments.
Increased Levels of Elastase and Osteopontin in the EDP-Treated Cells
Our results implied that an increase of elastase may result in the degradation of elastin and generate EDPs, eventually damaging the tendon structure in TLHB patients. To further examine the effects in the elastic fiber degeneration, Western blotting was used to determine the protein levels of elastase and osteopontin, a marker of osteogenic responses, 34, 35 in tenocytes after EDP treatment. EDP treatment increased the protein levels of elastase at the dosage of 100 ug/ml in TLHB tenocytes (Fig. 4A) ; it also increased the protein levels of osteopontin in TLHB tenocytes (Fig. 4B) . These results suggest that activation of elastase in TLHB increases the degradation of elastin to increase the levels of elastase, becoming a vicious cycle to the progressive severity of tendinopathy.
DISCUSSION
The current study revealed the distribution of elastic fibers for progressively severe tendinopathy, as well as the positive ratio of elastase in TLHB. We first demonstrated an obvious and consistent loss of elastic fibers and significantly increased elastase in TLHB. These results suggested that changes of elastin and the protein levels of elastase were involved in the development of TLHB. In a normal tendon, elastic fibers influence the local mechanical environment of the tenocytes and contribute to the microstructural deformation of the tendon. 36 Disarrangement of the tendon ECM proteins may result in the imbalance of the mechanical microenvironment, which leads to further damage of the tendon. Elastin synthesis may also be affected by elastase activity which results in the degradation of the elastin. 37 The partial proteolysis of elastin caused by activated elastase results in the release of soluble EDPs into blood circulation, 38 and EDPs may further regulate neutrophil elastase activity. 39 In previous studies, EDPs induced osteogenic responses and increased MMP activity in smooth muscle cells. Our results showed that EDPs enhance protein levels of elastase and osteopontin in tenocytes which were isolated from TLHB. Elastase increased elastin degradation to produce EDPs, which then further enhanced 14 Calcification also occurred in RCTs 15 and in TLHB, 16 but future studies are necessary to elucidate whether these mechanisms are similar to vascular diseases.
Elastic fibers comprise only 2% of the mass of a tendon and play critical mechanical functions within them. 40 Elastic fibers form a 3-D network of thin fibers that interpenetrate the array of collagen fibers and maintain the mechanical environments of tenocytes. 41 Therefore, inflammation-induced neutrophils-secreted elastase may hydrolyze elastin fibers and make the tendon susceptible to mechanical damage, as well as prohibit it from healing after injury. Because several different classes of protease are involved in matrix turnover during the breakdown of cartilage and bone, 42 the relationship between elastase and tendinopathy has not previously been studied.
The expression of elastase in other types of extensible tissues (e.g., muscular blood vessels and lungs) has been investigated. 43, 44 Released neutrophil elastase induces a protease-antiprotease imbalance, 45 which regulates chronic inflammation and destroys lung and artery elastin and fibronectin. It has been used in animal models of chronic obstructive pulmonary disease 46, 47 and to generate aortic aneurysms. 48 The mechanism of elastase used to generate an aorta aneurysm model in the cardiovascular system is thus believed to be caused by the breakdown of the elastin lamina. 49 This study has several limitations. First, because the control specimens were collected from fresh cadaver donors who were not diagnosed to have potential degenerative diseases. Judging from the range of these cadaveric donor (45-56 years old), it is unknown whether the tendons had any previous degeneration. We have made effort to eliminate the possible effects of the degenerative tendon in the control samples. Therefore, the number of useful normal tendon tissues to be served as control samples in the current study was limited. However, because we focused on studying the variation between various histological grades and observing the possible contribution of loss of elastic fiber and levels of elastase in the process of tendon degeneration (i.e., degeneration from grades I-II or III), these samples were required as a control. Second, the grading method used in this study was based on the use of collagen fibers without elastic fibers. Therefore, the process of degeneration for elastic fibers may not be the same as that for collagen fibers. Further research is necessary to resolve these problems.
Our data are also in agreement with the typical types I and III collagen changes published in previous studies. 6 These findings indicated that elastic fiber (a minor component of the ECM of a tendon) and collagen fibers underwent degeneration. In addition, our results suggested that the increased levels of elastase correlated with collagen and elastic fiber degeneration; however, the molecular mechanism used to define the features of this degeneration remains to be investigated. A more thorough understanding of the cellular changes exhibited by tendinopathy will allow for the creation of clinical cellular therapies that can impede its progression or improve the quality of surgical repair. Further study is required to confirm the role of elastase and elastic fiber change in the various stages of tendon breakdown in the experimental tendinopathy model.
In conclusion, we demonstrated that elastic fiber was significantly decreased in the moderate to severe Figure 4 . EDP upregulates elastase protein levels in human TLHB tenocytes. Primary culture of human tenocytes from passage 3 was used. Cells were cultured in 6-well plates (1.5 Â 10 5 /well) in Dulbecco's modified Eagle's medium. Experimental agents in culture medium were administered as follows: 20, 50, and 100 mg/ml EDP. Protein levels of elastase (A) and osteopontin (B) in tenocytes were analyzed after 24 h treatment by using Western blotting. Control was administered as serum free. The protein levels of a-tubulin were served as a loading control. Western blotting results were quantified using ImageJ image processing software (http://rsb.info.nih.gov/ij/).
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WU ET AL. stages of tendinopathy. EDPs caused elastase and osteopontin levels to increase. A significantly positive correlation also existed between the severity of tendinopathy and elastase activity, suggesting that these processes play a critical role in tendinopathy pathogenesis.
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